Alveus Therapeutics

Redefining Weight Management

Philadelphia, United States · Founded 2024 · $197.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$197.0M
Last Round
$37.0M Series AMar 2026
Rounds
2

About

Alveus Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and metabolic diseases. Its lead asset ALV-100 is currently in Phase 1b clinical trials, targeting sustainable weight loss with superior tolerability and reduced treatment burden. The company was founded in early 2024 and raised a $197 million Series A to advance its differentiated therapeutic pipeline.

Summary

Alveus Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2024. It has raised $197.0M in total across 2 rounds, most recently a $37.0M Series A round in Mar 2026. Investors include Andera Partners, Omega Funds and New Rhein.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$37.0M

Sign up to see all 2 rounds

Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alveus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alveus-therapeutics"><img src="https://indexed.vc/api/badge/company/alveus-therapeutics" alt="Alveus Therapeutics on Indexed.vc" width="260" height="76" /></a>